Latest from TCT 2017
A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.
Percutaneous coronary intervention of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI in patients with patients with multivessel CAD and acute MI.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.
Sign Up for Free e-Newsletters
Check out what's trending
The Cardiology Advisor Articles
- The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
- The Mounting Evidence Against Electronic Cigarette Use
- Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients
- Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
- Clinical Case: Pregnant Woman Presents With Worsening Dyspnea
- Sacubitril/Valsartan vs Enalapril for Physical Activity Improvement in HFrEF
- Improved Outcomes With CABG vs PCI for Diabetes With LV Dysfunction
- Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Cardiovascular Complications of COPD